MedPath

PGS on Blastocysts From Vitrified and Fresh Oocytes

Completed
Conditions
Increase the Number of Blastocyst to Biopsy for Preimplantation Genetic Testing
Registration Number
NCT02820415
Lead Sponsor
Unità di Medicina della Riproduzione, Italy
Brief Summary

Oocyte accumulation by vitrification is a valid strategy to increase the number of available embryos for biopsy and the number of viable euploid embryos to transfer after preimplantation genetic testing.

Detailed Description

In the present study, the investigators considered the hypothesis to accumulate vitrified oocytes with a view to increasing the number of oocytes for micro-injection and consequently the number of blastocyst to diagnose for patients with normal ovarian reserve and candidate for PGT. The partecipants were proposed to undergo several cycles of ovarian stimulation. In the first cycles, mature (metaphase II) oocytes were vitrified and consequently accumulated. In the last cycle, the freshly produced mature oocytes and the previously accumulated ones were micro-injected together with the same partner's semen sample. PGT was performed on blastocysts produced from the two sources of oocytes. The comprehensive chromosomal analysis of biopsied trophectoderm cells was performed using NGS technology. The number of available euploid blastocyst and the proportion of euploid/aneuploidy embryos from fresh and vitrified/warmed oocytes were compared. In conclusion the investigators evaluated the efficacy of oocyte accumulation by vitrification in increasing the number of available embryos for biopsy and the number of viable euploid embryos to transfer after PGT.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • infertile women
  • normal ovarian reserve
  • with repeated implantation failure or reccurent miscarriage
  • undergoing ICSI and asking to know the state of health of the embryos prior to embryo transfer
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rate of euploidy in blastocyst from fresh and vitrified/warmed oocytes1 year

from fresh and vitrified/warmed oocytes

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sandrine Chamayou

🇮🇹

Sant'agata Li Battiati, Italy

Sandrine Chamayou
🇮🇹Sant'agata Li Battiati, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.